LON:VENN - Venn Life Sciences Stock Price, News, & Analysis

GBX 6.80
0.00 (0.00 %)
(As of 06/28/2019)
Today's Range
6.70
Now: GBX 6.80
7
50-Day Range
2.65
MA: GBX 5.50
7.25
52-Week Range
1.45
Now: GBX 6.80
7.25
Volume1.52 million shs
Average Volume30,982 shs
Market Capitalization£4.85 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling. It also provides clinical trial services comprising clinical feasibility assessment, project management, clinical and medical monitoring, biometrics, biostatistics, data management and databases integration, ISC/IDMC, RTSM, investigator initiated studies, and resourcing and recruitment. In addition, the company offers regulatory affairs and consulting, quality assurance, and legal services, as well as drug development training and courses. The company has a strategic collaboration with Open Orphan DAC for the clinical research and regulatory consulting for companies developing products under the auspices of the various Orphan Drug frameworks. The company was founded in 2012 and is headquartered in Dublin, Ireland.

Industry, Sector and Symbol

Industry Medical Care
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+44-28-90737900

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book ValueGBX 15.60 per share

Profitability

Miscellaneous

Employees157
Market Cap£4.85 million
Next Earnings DateN/A
OptionableNot Optionable

Receive VENN News and Ratings via Email

Sign-up to receive the latest news and ratings for VENN and its competitors with MarketBeat's FREE daily newsletter.

Venn Life Sciences (LON:VENN) Frequently Asked Questions

What is Venn Life Sciences' stock symbol?

Venn Life Sciences trades on the London Stock Exchange (LON) under the ticker symbol "VENN."

Has Venn Life Sciences been receiving favorable news coverage?

Media headlines about VENN stock have been trending negative on Thursday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Venn Life Sciences earned a daily sentiment score of -2.7 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Venn Life Sciences.

Who are some of Venn Life Sciences' key competitors?

What other stocks do shareholders of Venn Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Venn Life Sciences investors own include Nielsen (NLSN), Biogen (BIIB), Arts-Way Manufacturing (ARTW), Adomani (ADOM), Adobe (ADBE), Achieve Life Sciences (ACHV), Allegiance Bancshares (ABTX), Scotgold Resources (SGZ), McBride (MCB) and Firestone Diamonds (FDI).

Who are Venn Life Sciences' key executives?

Venn Life Sciences' management team includes the folowing people:
  • Mr. Anthony Richardson, CEO, Exec. Director & Company Sec. (Age 55)
  • Dr. Christian Bernard Milla, COO & Director (Age 57)

How do I buy shares of Venn Life Sciences?

Shares of VENN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Venn Life Sciences' stock price today?

One share of VENN stock can currently be purchased for approximately GBX 6.80.

How big of a company is Venn Life Sciences?

Venn Life Sciences has a market capitalization of £4.85 million. Venn Life Sciences employs 157 workers across the globe.View Additional Information About Venn Life Sciences.

What is Venn Life Sciences' official website?

The official website for Venn Life Sciences is http://www.vennlifesciences.com/.

How can I contact Venn Life Sciences?

Venn Life Sciences' mailing address is 1 Berkeley Street, LONDON, W1J 8DJ, United Kingdom. The company can be reached via phone at +44-28-90737900.


MarketBeat Community Rating for Venn Life Sciences (LON VENN)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  73 (Vote Outperform)
Underperform Votes:  95 (Vote Underperform)
Total Votes:  168
MarketBeat's community ratings are surveys of what our community members think about Venn Life Sciences and other stocks. Vote "Outperform" if you believe VENN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VENN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel